Skip to Main Content

Paper Details

P300/CBP inhibition sensitizes mantle cell lymphoma to PI3Kδ inhibitor idelalisib.
Acta Pharmacol Sin
10
2022
Author NameAffiliation
Hualiang JiangThe Center for Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
  • 1 - 1

Datasets

Release 1.2